Cargando…

Birth weight and blood lipid levels in Spanish adolescents: Influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study

BACKGROUND: There is increasing evidence indicating that genes involved in certain metabolic processes of cardiovascular diseases may be of particular influence in people with low body weight at birth. We examined whether the apolipoprotein (APO) E, APOC3 and the peroxisome proliferator-activated re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz, Jonatan R, Labayen, Idoia, Ortega, Francisco B, Moreno, Luis A, González-Lamuño, Domingo, Martí, Amelia, Nova, Esther, Fuentes, Miguel García, Redondo-Figuero, Carlos, Martínez, J Alfredo, Sjöström, Michael, Castillo, Manuel J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615435/ https://www.ncbi.nlm.nih.gov/pubmed/19000312 http://dx.doi.org/10.1186/1471-2350-9-98

Ejemplares similares

AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters
por: Yang, Chun, et al.
Publicado: (2020)

PPARgamma Deficiency Counteracts Thymic Senescence
por: Ernszt, David, et al.
Publicado: (2017)

Sex differences in HDL ApoC-III in American Indian youth
por: Blackett, Piers R, et al.
Publicado: (2012)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
por: Borén, Jan, et al.
Publicado: (2020)

Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats
por: Yang, Baichun, et al.
Publicado: (2004)

ApoC-III is a novel inducer of calcification in human aortic valves
por: Schlotter, Florian, et al.
Publicado: (2021)

ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression
por: Zhou, Jiahe, et al.
Publicado: (2023)

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
por: Ramms, Bastian, et al.
Publicado: (2019)

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
por: Shen, B, et al.
Publicado: (2012)

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
por: Xu, Yitong, et al.
Publicado: (2022)

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans
por: Rout, Madhusmita, et al.
Publicado: (2022)

Intergenerational Cardiovascular Disease Risk Factors Involve Both Maternal and Paternal BMI
por: Labayen, Idoia, et al.
Publicado: (2010)

PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
por: Hernandez-Quiles, Miguel, et al.
Publicado: (2021)

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
por: Taskinen, Marja-Riitta, et al.
Publicado: (2019)

Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study
por: Martinez-Gomez, David, et al.
Publicado: (2009)

Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study
por: Hilbert, Michelle, et al.
Publicado: (2022)

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering
por: Ramms, Bastian, et al.
Publicado: (2022)

PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance
por: Todorov, Vladimir T.
Publicado: (2013)

Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation
por: Wen, Li-Li, et al.
Publicado: (2016)

Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan
por: Berkinbayev, S, et al.
Publicado: (2014)

APOE ɛ4 allele and TOMM40‐APOC1 variants jointly contribute to survival to older ages
por: Kulminski, Alexander M., et al.
Publicado: (2022)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy
por: Augimeri, Giuseppina, et al.
Publicado: (2021)

40 Years of the APOC Partnership
por: Roungou, Jean-Baptist, et al.
Publicado: (2015)

Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy
por: Foulkes, Andrea S, et al.
Publicado: (2006)

APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease
por: Zhou, Qin, et al.
Publicado: (2014)

Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
por: Sviridov, Denis, et al.
Publicado: (2023)

Validity of Resting Energy Expenditure Predictive Equations before and after an Energy-Restricted Diet Intervention in Obese Women
por: Ruiz, Jonatan R., et al.
Publicado: (2011)

Impact of COVID-19 Confinement on Physical Activity and Sedentary Behaviour in Spanish University Students: Role of Gender
por: Rodríguez-Larrad, Ana, et al.
Publicado: (2021)

ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity
por: Amaya-Montoya, Mateo, et al.
Publicado: (2020)

ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women
por: Sumner, Anne E, et al.
Publicado: (2013)

Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis
por: Morze, Jakub, et al.
Publicado: (2020)

IMPACT OF COMBINATIONS OF THE APOE Ɛ4 ALLELE AND TOMM40-APOC1 VARIANTS ON SURVIVAL TO OLDER AGES AND ALZHEIMER’S RISK
por: Kulminski, Alexander, et al.
Publicado: (2022)

ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC
por: Wang, Jing, et al.
Publicado: (2022)

APOC3: Triglycerides do matter
por: Hassan, Mohamed
Publicado: (2014)

Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis
por: Song, Yongyan, et al.
Publicado: (2015)

Spanish Fabry and Gaucher disease patients show striking differences in Beliefs about Medicines (BMQ) and Brief Illness Perception (BIPQ) questionnaires
por: González-Lamuño, Domingo, et al.
Publicado: (2022)

Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study
por: Martínez-Vizcaino, Vicente, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jte3m4dcq8t0016qcmmb2tmglc